Publicaciones Google Scholar de
1980 a
2024
| Título |
Fuente |
Fecha |
| CB1 Receptors In NG2 CELLS MEDIATE CANNABINOID-EVOKED FUNCTIONAL MYELIN REGENERATION |
Progress in Neurobiology, 102683 , 2024 |
2024 |
| Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice |
Biomedicine & Pharmacotherapy 174, 116473 , 2024 |
2024 |
| Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche’s … |
CHIMIA 78 (7-8), 499-512 , 2024 |
2024 |
| Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy |
Behavioral and Brain Functions 20 (1), 28 , 2024 |
2024 |
| From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline |
British journal of pharmacology , 2024 |
2024 |
| Implantación de un Servicio de Orientación Universitaria (SOU) en la Facultad de Ciencias Biológicas: Programa Integral de Acompañamiento y Seguimiento de Estudiantes |
|
2024 |
| The endocannabinoid system as a therapeutic target in neuropathic pain: a review |
Expert Opinion on Therapeutic Targets 28 (9), 739-755 , 2024 |
2024 |
| Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia |
Antioxidants 13 (9), 1072 , 2024 |
2024 |
| Preclinical Assessment of a Cannabinoid CB2 Receptor Antagonist in a Murine Model of Cerebral Malaria |
Journal of Trial and Error , 2024 |
2024 |
| EXPLORING THE MYELINATION STATUS IN A MURINE MODEL OF DRAVET SYNDROME |
IBRO Neuroscience Reports 15, S643 , 2023 |
2023 |
| USE OF CANNABINOIDS IN THE TREATMENT OF DYSKINESIA ASSOCIATED WITH PARKINSON'S DISEASE |
US Patent App. 17/638,629 , 2023 |
2023 |
| The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy |
Brain Sciences 13 (9), 1272 , 2023 |
2023 |
| Mammalian CDC14 phosphatases control exit from stemness in pluripotent cells |
The EMBO Journal 42 (1), e111251 , 2023 |
2023 |
| CANNABINOID CB1 RECEPTOR GENE INACTIVATION IN OLIGODENDROCYTE PRECURSORS DISRUPTS OLIGODENDROGENESIS AND MYELINATION IN MICE |
IBRO Neuroscience Reports 15, S137-S138 , 2023 |
2023 |
| Supplementary material for: Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship |
American Chemical Society , 2023 |
2023 |
| INVESTIGATING CANNABINOID SIGNALLING ACTIONS IN A NEURODEVELOPMENTAL MODEL OF CORTICAL LAMINARIZATION ALTERATIONS |
IBRO Neuroscience Reports 15, S94 , 2023 |
2023 |
| THE EFFICACY OF COMBINED TREATMENT WITH ΒETA-CARYOPHYLLENE AND CANNABIDIOL IN A MOUSE MODEL OF DRAVET SYNDROME |
IBRO Neuroscience Reports 15, S574 , 2023 |
2023 |
| ANALYZING THE INFLUENCE OF CANNABIS SATIVA COMPOUNDS ON THE MYELINATION PROCESS IN A MURINE MODEL OF DRAVET SYNDROME |
IBRO Neuroscience Reports 15, S644-S645 , 2023 |
2023 |
| PYRIDO [2, 3-d] PYRIMIDIN-7 (8H)-ONES AS CDK INHIBITORS |
US Patent App. 17/942,508 , 2023 |
2023 |
| Method for expanding stemness and differentiation potential of pluripotent cells |
US Patent 11,814,650 , 2023 |
2023 |
| Endocannabinoid-Binding Receptors as Drug Targets |
Endocannabinoid Signaling, 67-94 , 2023 |
2023 |
| miR-203 drives breast cancer cell differentiation |
Breast Cancer Research 25 (1), 91 , 2023 |
2023 |
| Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice |
Journal of Neuroinflammation 20 (1), 1-32 , 2023 |
2023 |
| CB 2 receptor in glial cells as a new therapeutic target in amyotrophic lateral sclerosis and frontotemporal dementia. |
GLIA 71, E304-E304 , 2023 |
2023 |
| Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43 |
Nature communications 14 (1), 2303 , 2023 |
2023 |
| TACE/ADAM17 Is Essential for Oligodendrocyte Development and CNS Myelination (vol 34, 11884, 2014) |
JOURNAL OF NEUROSCIENCE 43 (50), 8825-8826 , 2023 |
2023 |
| Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome |
Neuropharmacology, 109602 , 2023 |
2023 |
| NG2 cells mediate cannabinoid-induced functional recovery following demyelination |
IBRO Neuroscience Reports 15, S202 , 2023 |
2023 |
| Retinal neurodegeneration and neuroinflammation in a SOD1 mouse model of ALS |
Acta Ophthalmologica 100 , 2022 |
2022 |
| New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia |
Biomolecules 12 (9), 1200 , 2022 |
2022 |
| Cannabinoid CB 1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice |
Cell Death & Disease 13 (7), 585 , 2022 |
2022 |
| Prenatal THC exposure interferes with the neurodevelopmental role of endocannabinoid signaling |
Cannabis and the Developing Brain, 259-282 , 2022 |
2022 |
| Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome |
Elsevier , 2022 |
2022 |
| Endocannabinoid-Binding Receptors as Drug Targets |
Endocannabinoid Signaling: Methods and Protocols 2576, 67 , 2022 |
2022 |
| Buenas prácticas contra el estigma: el ejemplo de la Cátedra UCM-Grupo 5 Contra el Estigma |
Documentación social, 2 , 2022 |
2022 |
| Cannabinoid CB 1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse |
Frontiers in Neuroanatomy 16, 1030060 , 2022 |
2022 |
| Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure–Activity Relationship |
ACS Medicinal Chemistry Letters , 2022 |
2022 |
| New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Biomolecules 2022, 12, 1200 |
s Note: MDPI stays neutral with regard to jurisdictional claims in published … , 2022 |
2022 |
| The stigma of mental health, homelessness and intellectual disability, development of a national stigma survey with an intersectional gender perspective |
International Journal of Clinical Trials 9 (4), 286-292 , 2022 |
2022 |
| TDP-43 modulation by tau-tubulin kinase 1 inhibitors: A new avenue for future amyotrophic lateral sclerosis therapy |
Journal of Medicinal Chemistry 65 (2), 1585-1607 , 2022 |
2022 |
| Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations |
International Journal of Molecular Sciences 23 (20), 12676 , 2022 |
2022 |
| Δ 9 ‐Tetrahydrocannabinol promotes functional remyelination in the mouse brain |
British Journal of Pharmacology 178 (20), 4176-4192 , 2021 |
2021 |
| Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis |
International Journal of Molecular Sciences 22 (16), 8975 , 2021 |
2021 |
| Recent advances in the pathogenesis and therapeutics of amyotrophic lateral sclerosis |
British Journal of Pharmacology 178 (6), 1253-1256 , 2021 |
2021 |
| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 |
autophagy 17 (1), 1-382 , 2021 |
2021 |
| Use of cannabinoids in the treatment of a neurodegenerative disease or disorder |
US Patent App. 16/629,722 , 2021 |
2021 |
| (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice |
Pharmacological Research, 105492 , 2021 |
2021 |
| P. 0357 Effect of a combination therapy with cannabidiol and β-caryophyllene in SCN1A-A1783V mice, an experimental model of dravet syndrome |
European Neuropsychopharmacology 53, S259-S260 , 2021 |
2021 |
| Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis |
Molecules 26 (24), 7643 , 2021 |
2021 |
| Recent advances in the pathogenesis and therapeutics of amyotrophic lateral sclerosis (vol 178, pg 1253, 2021) |
BRITISH JOURNAL OF PHARMACOLOGY 178 (10), 2162-2162 , 2021 |
2021 |
| BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis |
International Journal of Molecular Sciences 22 (22), 12533 , 2021 |
2021 |
| Effect of a combination therapy with cannabidiol and beta-caryophyllene in SCN1A-A1783V mice, an experimental model of dravet syndrome |
EUROPEAN NEUROPSYCHOPHARMACOLOGY 53, S259-S260 , 2021 |
2021 |
| Inactivation of the CB 2 receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis |
Brain Pathology, e12972 , 2021 |
2021 |
| Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration |
Acta neuropathologica communications 9 (1), 1-18 , 2021 |
2021 |
| Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis |
British journal of pharmacology 178 (6), 1373-1387 , 2021 |
2021 |
| Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease |
European Journal of Pharmacology 895, 173875 , 2021 |
2021 |
| Inactivation of the CB 2 receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis |
Brain Pathology 31 (6), e12972 , 2021 |
2021 |
| Retinal microglial activation in a SOD1 mouse model of ALS |
Acta Ophthalmologica 99 , 2021 |
2021 |
| Cross-cultural analysis of spiritual bypass: A comparison between Spain and Honduras |
Frontiers in psychology 12, 658739 , 2021 |
2021 |
| Self-compassion and social connectedness as predictors of “peace and meaning” during Spain’s initial COVID-19 lockdown |
Religions 12 (9), 683 , 2021 |
2021 |
| Self-Compassion and Social Connectedness as Predictors of Peace and Meaning” during Spain’s Initial COVID-19 Lockdown. Religions 12: 683 |
s Note: MDPI stays neutral with regard to jurisdictional claims in published … , 2021 |
2021 |
| Cover Image, Volume 69, Issue 3 |
Glia 69 (3), C1-C1 , 2021 |
2021 |
| The role of the sense of belonging during the alarm situation and return to the new normality of the 2020 coronavirus pandemic (COVID-19) in Spain |
Psychological Studies 66, 326-336 , 2021 |
2021 |
| Spirituality and employment in recovery from severe and persistent mental illness and psychological well-being |
Healthcare 9 (1), 57 , 2021 |
2021 |
| Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease |
Molecules 26 (11), 3245 , 2021 |
2021 |
| Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis |
European Journal of Medicinal Chemistry 210, 112968 , 2021 |
2021 |
| Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice |
Molecular and Cellular Neuroscience 110, 103583 , 2021 |
2021 |
| Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome |
Neuropharmacology, 108914 , 2021 |
2021 |
| Identification of BiP as a CB1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain |
Journal of Neuroscience 41 (38), 7924-7941 , 2021 |
2021 |
| Δ 9 ‐Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo |
Glia 69 (3), 532-545 , 2021 |
2021 |
| Retinal Ganglion Cell Loss and Microglial Activation in a SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis |
International Journal of Molecular Sciences 22 (4), 1663 , 2021 |
2021 |
| Δ 9 ‐Tetrahydrocannabinolic acid alleviates collagen‐induced arthritis: Role of PPARγ and CB 1 receptors |
British journal of pharmacology 177 (17), 4034-4054 , 2020 |
2020 |
| Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from Von Hippel–Lindau disease |
Journal of Clinical Medicine 9 (9), 2740 , 2020 |
2020 |
| Raloxifene and n -Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa |
Cells 9 (9), 2108 , 2020 |
2020 |
| Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB 1 receptors |
Development 147 (24), dev192161 , 2020 |
2020 |
| Beneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease |
Neurobiology of disease 141, 104892 , 2020 |
2020 |
| Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination |
Elife 9, e56811 , 2020 |
2020 |
| Phytocannabinoids Versus Endocannabinoids. A Modern View of the Endocannabinoid System |
New Tools to Interrogate Endocannabinoid Signalling, 10-47 , 2020 |
2020 |
| Inhibidores de TGF-ß1 y productores de endoglina para su uso en el tratamiento de epidermólisis bullosa |
|
2020 |
| Cannabinoid-induced motor dysfunction via autophagy inhibition |
Autophagy 16 (12), 2289-2291 , 2020 |
2020 |
| Possible therapeutic applications of cannabis in the neuropsychopharmacology field |
European Neuropsychopharmacology 36, 217-234 , 2020 |
2020 |
| Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment |
Scientific Reports (Nature Publisher Group) 10 (1) , 2020 |
2020 |
| Determinación del coeficiente de variación del consumo diario de agua potable en ciudades menores a 150000 habitantes |
Tesis de Pregrado, Universidad Nacional de Chimborazo , 2020 |
2020 |
| Inhibitors of TFG-B1 and endoglin producers for use in the treatment of epidermolysis bullosa |
|
2020 |
| Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders |
Biomolecules 10 (2), 279 , 2020 |
2020 |
| Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure |
Neuropsychopharmacology 45 (5), 877-886 , 2020 |
2020 |
| Treatment and prevention of glioblastoma |
|
2020 |
| Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment |
Scientific Reports 10 (1), 1-12 , 2020 |
2020 |
| miR-203 imposes an intrinsic barrier during cellular reprogramming by targeting NFATC2 |
bioRxiv, 2020.06. 02.131136 , 2020 |
2020 |
| Jornadas sobre la carrera investigadora: Módulo I, primera sesión: Etapas de la carrera Investigadora (predoctoral y postdoctoral). |
|
2020 |
| Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor |
Chemistry (Weinheim an der Bergstrasse, Germany) 26 (68), 15839 , 2020 |
2020 |
| Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB Receptor |
Chemistry-A European Journal 26, 15839-15842 , 2020 |
2020 |
| Transient exposure to miR‐203 enhances the differentiation capacity of established pluripotent stem cells |
The EMBO Journal 39 (16), e104324 , 2020 |
2020 |
| Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination |
eLife Sciences Publications , 2020 |
2020 |
| Cannabinoid-induced motor dysfunction via autophagy inhibition |
Taylor & Francis , 2020 |
2020 |
| Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment |
Scientific reports 10 (1), 4449 , 2020 |
2020 |
| Neuropathological characterization of a Dravet síndrome knock-in mouse model useful for investigating cannabinoid treatments |
Frontiers in Molecular Neuroscience 13, 241 , 2020 |
2020 |
| Transient exposure to miR-203 expands the differentiation capacity of pluripotent stem cells |
The EMBO Journal, 2020, e104324 , 2020 |
2020 |
| Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma |
Scientific Reports 9 (1), 5179 , 2019 |
2019 |
| Morphine self-administration alters the expression of translational machinery genes in the amygdala of male Lewis rats |
Journal of Psychopharmacology 33 (7), 882-893 , 2019 |
2019 |
| Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons |
Neuropharmacology 150, 134-144 , 2019 |
2019 |
| Description of attitudes about professional ethics in students of two professional schools of health, 2016. |
|
2019 |
| Acute Delta 9-tetrahydrocannabinol administration accelerates oligodendrocyte development and regeneration |
GLIA 67, E681-E682 , 2019 |
2019 |
| Phosphorylation of FOXO proteins as a key mechanism to regulate their activity |
FOXO Transcription Factors: Methods and Protocols, 51-59 , 2019 |
2019 |
| Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease |
Molecules 24 (15), 2702 , 2019 |
2019 |
| Characterisation of a new model of frontotemporal dementia for neuroprotective studies with cannabinoids |
EUROPEAN NEUROPSYCHOPHARMACOLOGY 29, S664-S665 , 2019 |
2019 |
| IVRA: Romans, Visigoths and Byzantines. An experience of teaching innovation in the key of gender |
Rev. Educ. Derecho 20, 1-34 , 2019 |
2019 |
| Relaciones sociales y prácticas cotidianas del habitante de calle en Medellín, Colombia |
Revista Psicológica em Pesquisa 13 (1), 33-41 , 2019 |
2019 |
| The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid‐based therapies to improve on the poor current therapeutic outcomes |
British journal of pharmacology 176 (10), 1370-1383 , 2019 |
2019 |
| Endocannabinoid system in spinocerebellar ataxia type-3 and other autosomal-dominant cerebellar ataxias: Potential role in pathogenesis and expected relevance as … |
Frontiers in molecular neuroscience 12, 94 , 2019 |
2019 |
| Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease |
MDPI , 2019 |
2019 |
| Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma |
Oncogene 38 (23), 4620-4636 , 2019 |
2019 |
| A novel microRNA-based strategy to expand the differentiation potency of stem cells |
bioRxiv, 826446 , 2019 |
2019 |
| Targeting glial cannabinoid CB 2 receptors to delay the progression of the pathological phenotype in TDP‐43 (A315T) transgenic mice, a model of amyotrophic … |
British journal of pharmacology 176 (10), 1585-1600 , 2019 |
2019 |
| 11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells |
Scientific Reports 9 (1), 11916 , 2019 |
2019 |
| Descripción de actitudes sobre ética profesional en estudiantes de dos escuelas profesionales en el área de salud, 2016 |
Anales de la Facultad de Medicina 80 (3), 342-345 , 2019 |
2019 |
| Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia |
Frontiers in Pharmacology 9, 1508 , 2019 |
2019 |
| Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration |
Translational neurodegeneration 8, 1-15 , 2019 |
2019 |
| Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives |
Frontiers in Pharmacology 10 , 2019 |
2019 |
| Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration |
|
2019 |
| Multifunctional albumin-stabilized gold nanoclusters for the reduction of cancer stem cells |
Cancers 11 (7), 969 , 2019 |
2019 |
| 4.-Cannabinoides en el tratamiento de las enfermedades neurodegenerativas |
Usos medicinales del cannabis:¿ qué sabemos de sus propiedades curativas?, 61-80 , 2019 |
2019 |
| Upper corticospinal motor neurons, methods and compositions for differentiating neural stem cells by modulating CB1 cannabinoid receptor signaling and uses thereof |
|
2018 |
| Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum |
Neuropsychopharmacology, 2018, vol. 43, num. 5, p. 964-977 , 2018 |
2018 |
| Ingroducción a la farmacología del sistema nervioso central: neurotransmisores, receptores y otros elementos sinápticos |
Velázquez. Farmacología básica y clínica, 179-208 , 2018 |
2018 |
| Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders |
Elsevier , 2018 |
2018 |
| Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system |
Biochemical pharmacology , 2018 |
2018 |
| Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB 1 Receptors |
Cerebral Cortex 28 (1), 307-322 , 2018 |
2018 |
| Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders |
Biochemical Pharmacology 157, 85-96 , 2018 |
2018 |
| Corticospinal upper motor neurons, methods and compositions for differentiating neural stem cells by modulating CB1 cannabinoid receptor signaling and applications thereof |
|
2018 |
| Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients |
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19 (5-6), 377-386 , 2018 |
2018 |
| Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists |
Bioorganic & medicinal chemistry 26 (1), 295-307 , 2018 |
2018 |
| Modulation of the mTOR pathway in male Lewis rats after morphine self-administration and subsequent extinction training |
bioRxiv, 276121 , 2018 |
2018 |
| Singular location and signaling profile of adenosine A2A-cannabinoid CB1 receptor heteromers in the dorsal striatum |
Neuropsychopharmacology 43 (5), 964-977 , 2018 |
2018 |
| Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of … |
Journal of neuroinflammation 15 (1), 19 , 2018 |
2018 |
| Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients |
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19 (5-6), 377-386 , 2018 |
2018 |
| Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis |
Biochemical pharmacology 157, 217-226 , 2018 |
2018 |
| Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma |
Biochemical pharmacology 157, 275-284 , 2018 |
2018 |
| Corticospinal upper motor neurons, methods and compositions for differentiating neural stem cells by modulating CB1 cannabinoid receptor signaling and uses thereof |
|
2018 |
| Characterisation of a Dravet syndrome knock-in mouse model useful for investigating cannabinoid-based treatments |
European Neuropsychopharmacology 28, S41 , 2018 |
2018 |
| Preface: Why a Special Issue on cannabinoid research in Spain? |
Biochemical Pharmacology 157, 1-7 , 2018 |
2018 |
| VCE‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB 2 receptor‐dependent … |
British journal of pharmacology 175 (19), 3813-3831 , 2018 |
2018 |
| Telomere length defines the cardiomyocyte differentiation potency of mouse induced pluripotent stem cells |
Stem Cells 35 (2), 362-373 , 2017 |
2017 |
| Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelinization in newborn rats |
GLIA 65, E340-E340 , 2017 |
2017 |
| Loss of Cannabinoid CB1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility |
Cerebral Cortex 27 (11), 5303-5317 , 2017 |
2017 |
| Fueling the cell division cycle |
Trends in cell biology 27 (1), 69-81 , 2017 |
2017 |
| Synthesis of a novel CB cannabinoid-porphyrin conjugate based on an antitumor chromenopyrazoledione |
Journal of Porphyrins and Phthalocyanines 21 (01), 67-76 , 2017 |
2017 |
| Modeling neurodegenerative disorders for developing cannabinoid-based neuroprotective therapies |
Methods in enzymology 593, 175-198 , 2017 |
2017 |
| Corrigendum to" Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile"[Pharmacol. Res. 110 (August 2016 … |
Pharmacological research 120, 302 , 2017 |
2017 |
| DEVELOPMENT OF NEUROPROTECTIVE THERAPIES WITH PHYTOCANNABINOIDS FOR NEURODEGENERATIVE DISORDERS |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 121, 15-16 , 2017 |
2017 |
| New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking |
European journal of medicinal chemistry 127, 398-412 , 2017 |
2017 |
| Análisis del tratamiento periodístico de la Información científica en el diario El Comercio. Caso: Células Madre |
Universidad Católica Santo Toribio de Mogrovejo, Chiclayo , 2017 |
2017 |
| Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3 |
PloS one 12 (4), e0176521 , 2017 |
2017 |
| Formación de biopelículas por Listeria monocytogenes aisladas de queso fresco de mercados del Cercado de Lima |
Anales de la Facultad de Medicina 78 (3), 322-325 , 2017 |
2017 |
| Cannabinoid type-2 receptor drives neurogenesis and improves functional outcome after stroke |
stroke 48 (1), 204-212 , 2017 |
2017 |
| Materiales Didácticos y Virtualidad como base para el estudio de la mujer en la Antigüedad |
Experiencias de innovación docente en enseñanza superior de Castilla-La … , 2017 |
2017 |
| Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis |
Disease models & mechanisms 10 (5), 551-558 , 2017 |
2017 |
| Análisis del tratamiento periodístico de la información científica en el diario El Comercio |
Caso: células madre , 2017 |
2017 |
| Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders |
Frontiers in pharmacology 8, 269 , 2017 |
2017 |
| Aumentando la presencia de la UCM en los MOOCs: Puesta en marcha de un curso online sobre neurociencia |
|
2017 |
| Cannabinoids as regulators of neural development and adult neurogenesis |
Lipidomics of Stem Cells, 117-136 , 2017 |
2017 |
| Effects of a sativex-like combination of phytocannabinoids on disease progression in R6/2 mice, an experimental model of huntington’s disease |
International journal of molecular sciences 18 (4), 684 , 2017 |
2017 |
| Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer |
Cell Death & Differentiation, 1-13 , 2017 |
2017 |
| Programmed mitophagy is essential for the glycolytic switch during cell differentiation |
The EMBO journal 36 (12), 1688-1706 , 2017 |
2017 |
| Loss of Cannabinoid CB 1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility |
Cerebral Cortex 27 (11), 5303-5317 , 2017 |
2017 |
| Sustained Gq-protein signaling disrupts striatal circuits via JNK |
Journal of Neuroscience 36 (41), 10611-10624 , 2016 |
2016 |
| Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization |
Autophagy 12 (11), 2213-2229 , 2016 |
2016 |
| Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3. |
Elsevier , 2016 |
2016 |
| Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile |
Pharmacological research 110, 205-215 , 2016 |
2016 |
| Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer. |
Oncotarget 7 (30) , 2016 |
2016 |
| Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome |
Pharmacology research & perspectives 4 (2), e00220 , 2016 |
2016 |
| Targeting cannabinoid CB2 receptors in the Central Nervous System. Medicinal chemistry approaches and focus on neurodegenerative disorders affecting movement |
Frontiers in Neuroscience, 2016, vol. 10 , 2016 |
2016 |
| The new antitumor drug ABTL0812 inhibits the Akt/mTORC1 axis by upregulating tribbles-3 pseudokinase |
Clinical Cancer Research 22 (10), 2508-2519 , 2016 |
2016 |
| VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease |
Scientific reports 6, 29789 , 2016 |
2016 |
| A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease |
Journal of neurology 263 (7), 1390-1400 , 2016 |
2016 |
| Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice |
Pharmacological research 110, 181-192 , 2016 |
2016 |
| Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia |
British journal of pharmacology 173 (13), 2069-2079 , 2016 |
2016 |
| Postnatal telomere dysfunction induces cardiomyocyte cell-cycle arrest through p21 activation |
Journal of Cell Biology 213 (5), 571-583 , 2016 |
2016 |
| Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease |
Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, 200-208 , 2016 |
2016 |
| VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease |
Scientific reports 6 (1), 29789 , 2016 |
2016 |
| The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 … |
Scientific reports 6, 21703 , 2016 |
2016 |
| MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling |
Neuropharmacology 108, 345-352 , 2016 |
2016 |
| The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase |
AMER ASSOC CANCER RESEARCH , 2016 |
2016 |
| Possible dysregulation of the endocannabinoid system in a cohort of patients with Dravet syndrome |
European Neuropsychopharmacology 2 (26), S251 , 2016 |
2016 |
| Chromenopyrazole, a versatile cannabinoid scaffold with in vivo activity in a model of multiple sclerosis |
Journal of medicinal chemistry 59 (14), 6753-6771 , 2016 |
2016 |
| Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders |
Frontiers in neuroscience 10, 406 , 2016 |
2016 |
| Competition between members of the tribbles pseudokinase protein family shapes their interactions with mitogen activated protein kinase pathways |
Scientific Reports 6 (1), 1-12 , 2016 |
2016 |
| Identification of novel GPR55 modulators using cell-impedance-based label-free technology |
Journal of medicinal chemistry 59 (5), 1840-1853 , 2016 |
2016 |
| Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist … |
European journal of medicinal chemistry 112, 66-80 , 2016 |
2016 |
| Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3 |
Neuroscience 339, 191-209 , 2016 |
2016 |
| A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease |
Journal of neurology 263, 1390-1400 , 2016 |
2016 |
| Anticancer mechanisms of cannabinoids |
Current Oncology 23 (2), S23 , 2016 |
2016 |
| Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts |
Springerplus 4 (1), 168 , 2015 |
2015 |
| Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption |
European neuropsychopharmacology 25 (6), 958-965 , 2015 |
2015 |
| Oncosuppressive functions of tribbles pseudokinase 3. |
Biochemical Society Transactions 43 (5) , 2015 |
2015 |
| ABTL0812, a new antitumor drug that inhibits the axis Akt/mTOR through a novel mechanism of action |
Cancer Research 75 (15_Supplement), 672-672 , 2015 |
2015 |
| Mitophagy in mitosis: more than a myth |
Autophagy 11 (12), 2379-2380 , 2015 |
2015 |
| Endocannabinoids and neurodegenerative disorders: Parkinson’s disease, Huntington’s chorea, Alzheimer’s disease, and others |
Endocannabinoids, 233-259 , 2015 |
2015 |
| The endocannabinoid system is altered in the post‐mortem prefrontal cortex of alcoholic subjects |
Addiction biology 20 (4), 773-783 , 2015 |
2015 |
| Telomerase is essential for zebrafish heart regeneration |
Cell reports 12 (10), 1691-1703 , 2015 |
2015 |
| Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders |
Journal of Neuroimmune Pharmacology 10 (2), 233-244 , 2015 |
2015 |
| Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders |
Journal of Neuroimmune Pharmacology 10, 233-244 , 2015 |
2015 |
| Carmen Aurora Rodríguez Cueto |
UNIVERSIDAD COMPLUTENSE DE MADRID , 2015 |
2015 |
| The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway |
Cell Death & Differentiation 22 (10), 1618-1629 , 2015 |
2015 |
| TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling |
Molecular & cellular oncology 2 (3), e980134 , 2015 |
2015 |
| Telomerase Is Essential for Zebrafish Heart Regeneration |
Cross Mark , 2015 |
2015 |
| Endocannabinoids and cancer |
Endocannabinoids, 449-472 , 2015 |
2015 |
| Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer |
Journal of the National Cancer Institute 107 (6), djv077 , 2015 |
2015 |
| Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation |
Cell Death & Differentiation 22 (1), 131-144 , 2015 |
2015 |
| Selective, Nontoxic CB 2 Cannabinoid o -Quinone with in Vivo Activity against Triple-Negative Breast Cancer |
Journal of medicinal chemistry 58 (5), 2256-2264 , 2015 |
2015 |
| Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonists |
European journal of medicinal chemistry 101, 651-667 , 2015 |
2015 |
| Novel chromene quinones for modulating cannabinoid receptors cb2having antitumor activity |
|
2015 |
| Cannabinoids in neurodegenerative disorders and stroke/brain trauma: from preclinical models to clinical applications |
Neurotherapeutics 12 (4), 793-806 , 2015 |
2015 |
| Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease |
Neuroscience letters 587, 1-4 , 2015 |
2015 |
| Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons |
Proceedings of the National Academy of Sciences 112 (44), 13693-13698 , 2015 |
2015 |
| The endocannabinoid system controls radial glia transition to intermediate progenitor cells via mTORC1 signalling |
GLIA 63, E34-E34 , 2015 |
2015 |
| Papel de la autofagia en el mecanismo de acción antitumoral de los cannabinoides |
Universidad Complutense de Madrid , 2015 |
2015 |
| CDK6 as a key regulator of hematopoietic and leukemic stem cell activation |
Blood, The Journal of the American Society of Hematology 125 (1), 90-101 , 2015 |
2015 |
| Altered CB 1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects |
Journal of Psychopharmacology 29 (11), 1137-1145 , 2015 |
2015 |
| CANNABIDIOL PREVENTS POST-HYPOXIC-ISCHEMIC HYPOMIELINISATION BY RESTORING MATURE OLIGODENDROCYTE FUNCTION IN NEWBORN RATS |
Journal of Perinatal Medicine 43 , 2015 |
2015 |
| Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation |
Cell Death & Differentiation 22 (1), 131-144 , 2015 |
2015 |
| The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9 … |
Multiple sclerosis and related disorders 4 (6), 505-511 , 2015 |
2015 |
| TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling |
Molecular & Cellular Oncology 2 (3), e980134 , 2015 |
2015 |
| Endocannabinoids and amyotrophic lateral sclerosis |
Cannabinoids in Neurologic and Mental Disease, 99-123 , 2015 |
2015 |
| AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation |
Nature cell biology 17 (1), 20-30 , 2015 |
2015 |
| New inhibitors of angiogenesis with antitumor activity in vivo |
Journal of medicinal chemistry 58 (9), 3757-3766 , 2015 |
2015 |
| Activation of the endomitotic spindle assembly checkpoint and thrombocytopenia in Plk1-deficient mice |
Blood, The Journal of the American Society of Hematology 126 (14), 1707-1714 , 2015 |
2015 |
| AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest |
Nature cell biology 17 (10), 1304-1316 , 2015 |
2015 |
| CB 1 Cannabinoid Receptor-Dependent Activation of mTORC1/Pax6 Signaling Drives Tbr2 Expression and Basal Progenitor Expansion in the Developing Mouse … |
Cerebral cortex 25 (9), 2395-2408 , 2015 |
2015 |
| Nuevas cromenoquinonas moduladoras de receptores cannabinoides CB2 con actividad antitumoral |
|
2015 |
| A Sativex®‐like combination of phytocannabinoids as a disease‐modifying therapy in a viral model of multiple sclerosis |
British journal of pharmacology 172 (14), 3579-3595 , 2015 |
2015 |
| A restricted population of CB1 cannabinoid receptors with neuroprotective activity |
Proceedings of the National Academy of Sciences 111 (22), 8257-8262 , 2014 |
2014 |
| Phytocannabinoids for use in the treatment of breast cancer |
US Patent App. 14/352,390 , 2014 |
2014 |
| Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1 G93A Transgenic Mice and Evaluation of a Sativex ® ‐like Combination of … |
CNS neuroscience & therapeutics 20 (9), 809-815 , 2014 |
2014 |
| Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results |
Drug design, development and therapy 8, 263 , 2014 |
2014 |
| Chromenopyrazole diones as cannabinoid quinone derivatives having anti-tumour activity |
|
2014 |
| Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease |
European journal of medicinal chemistry 73, 56-72 , 2014 |
2014 |
| Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias |
Pathobiology 81 (3), 149-159 , 2014 |
2014 |
| Changes in CB 1 and CB 2 receptors in the post‐mortem cerebellum of humans affected by spinocerebellar ataxias |
British journal of pharmacology 171 (6), 1472-1489 , 2014 |
2014 |
| Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling |
Journal of Biological Chemistry, 2014, vol. 289, num. 32, p. 21960-21972 , 2014 |
2014 |
| Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice |
Neurobiology of aging 35 (12), 2858-2869 , 2014 |
2014 |
| Carcinogenesis & Mutagenesis |
|
2014 |
| Cannabinoids and the brain: New hopes for new therapies |
Cannabinoids, 175-218 , 2014 |
2014 |
| Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders |
Epilepsia 55 (6), 791-802 , 2014 |
2014 |
| Emerging Role of the Peroxisome Proliferator-Activated Receptors in Hepatocellular 13 Carcinoma. |
Carcinogenesis & Mutagenesis , 2014 |
2014 |
| Estefanía Moreno1, 2, 3, Clara Andradas4, 5, Mireia Medrano1, 2, 3, María M. Caffarel4, 6, Eduardo Pérez-Gómez4, 5, Sandra Blasco-Benito4, 5, María Gómez-Cañas7, 2, 8, M Ruth … |
|
2014 |
| CDK6 as a key regulator of hematopoietic and leukemic stem cell activation |
|
2014 |
| Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling |
Journal of Biological Chemistry 289 (32), 21960-21972 , 2014 |
2014 |
| Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors |
Neuropharmacology 75, 155-163 , 2013 |
2013 |
| The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action |
Biochimica Et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids … , 2013 |
2013 |
| The CB1 cannabinoid receptor drives corticospinal motor neuron differentiation through Ctip2/Satb2 transcriptional regulation axis |
JOURNAL OF NEUROCHEMISTRY 125, 167-167 , 2013 |
2013 |
| Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21 |
Bioorganic & medicinal chemistry 21 (7), 1708-1716 , 2013 |
2013 |
| Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy |
Journal of Alzheimer's Disease 35 (3), 525-539 , 2013 |
2013 |
| Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation |
Progress in lipid research 52 (4), 633-650 , 2013 |
2013 |
| Neuroprotective properties of standardized extracts of hypericum perforatum on rotenone model of Parkinson’s disease |
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS … , 2013 |
2013 |
| The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of … |
Cell death & disease 4 (10), e862-e862 , 2013 |
2013 |
| Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity |
European journal of medicinal chemistry 70, 111-119 , 2013 |
2013 |
| Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? |
British journal of clinical pharmacology 75 (2), 323-333 , 2013 |
2013 |
| Cannabinoids, neurogenesis and antidepressant drugs: is there a link? |
Current neuropharmacology 11 (3), 263-275 , 2013 |
2013 |
| 026 Química. Investigaciones en fármacos cannabinoides para las enfermedades neurológicas |
La uni en la calle: Libro de textos., 68-69 , 2013 |
2013 |
| ALTERED BDNF EXPRESSION AND CB1-RECEPTOR FUNCTIONALITY IN THE BRAIN OF GFAP KNOCKOUT MICE EXHIBITING AN ANXIOGENIC-LIKE BEHAVIOR |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 113, 46-46 , 2013 |
2013 |
| The Role of GPR55 in Cancer |
endoCANNABINOIDS, 115-133 , 2013 |
2013 |
| Experiencia sobre la evaluación continúa a través del Campus Virtual |
Valorar, validar y difundir Campus Virtual, 207-210 , 2013 |
2013 |
| Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors |
Multiple Sclerosis Journal 19 (14), 1896-1904 , 2013 |
2013 |
| Description of a bivalent cannabinoid ligand with hypophagic properties |
Archiv der Pharmazie 346 (3), 171-179 , 2013 |
2013 |
| Design and synthesis of novel cannabinoid ligands based on a 1, 2, 3-triazole scaffold |
Letters in Drug Design & Discovery 10 (2), 169-172 , 2013 |
2013 |
| Anandamide deficiency and heightened neuropathic pain in aged mice |
Neuropharmacology 71, 204-215 , 2013 |
2013 |
| The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system |
International Journal of Neuropsychopharmacology 16 (6), 1407-1419 , 2013 |
2013 |
| The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas |
Oncogene 32 (20), 2534-2542 , 2013 |
2013 |
| Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB1 and CB2 receptors |
ACS chemical neuroscience 3 (5), 400-406 , 2012 |
2012 |
| Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases |
Neuroscience letters 508 (2), 67-72 , 2012 |
2012 |
| CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling |
Journal of Biological Chemistry 287 (2), 1198-1209 , 2012 |
2012 |
| Chromenopyrazoles: Non-psychoactive and Selective CB 1 Cannabinoid Agonists with Peripheral Antinociceptive Properties |
Wiley-VCH , 2012 |
2012 |
| Cannabidiol administration after hypoxia–ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function |
Neuropharmacology 63 (5), 776-783 , 2012 |
2012 |
| Fármacos cannabinoides para las enfermedades neurológicas:¿ qué hay detrás? |
revista de Neurología 54, 613-28 , 2012 |
2012 |
| The CB1 cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis |
Journal of Neuroscience 32 (47), 16651-16665 , 2012 |
2012 |
| Cannabinoid drugs for neurological diseases: what is behind? |
Revista de neurologia 54 (10), 613-628 , 2012 |
2012 |
| Towards the use of cannabinoids as antitumour agents |
Nature Reviews Cancer 12 (6), 436-444 , 2012 |
2012 |
| ER Stress As Modulator of Autophagy Pathways |
Endoplasmic Reticulum Stress in Health and Disease, 163-184 , 2012 |
2012 |
| CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling |
Elsevier , 2012 |
2012 |
| 3.119 STRIATAL LONG-TERM DEPRESSION AND DOPAMINE SIGNALING IMPAIRMENT IN A53T-ALPHA-SYNUCLEIN OVEREXPRESSING MICE |
Parkinsonism & Related Disorders 18, S193-S194 , 2012 |
2012 |
| Quinone derivatives of chromenopyrazoles as cannabinoid ligands with antitumor activity in vivo |
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 244 , 2012 |
2012 |
| Chromenopyrazoles: Non‐psychoactive and Selective CB 1 Cannabinoid Agonists with Peripheral Antinociceptive Properties |
ChemMedChem 7 (3), 452-463 , 2012 |
2012 |
| Inside Back Cover: Chromenopyrazoles: Non‐psychoactive and Selective CB 1 Cannabinoid Agonists with Peripheral Antinociceptive Properties (ChemMedChem … |
ChemMedChem 7 (3), 536-536 , 2012 |
2012 |
| Cannabis, endocannabinoids and neurodevelopment |
Marijuana and Madness 66 , 2012 |
2012 |
| A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis |
Journal of Neuroimmune Pharmacology 7 (4), 1002-1016 , 2012 |
2012 |
| Endocannabinoids via CB 1 receptors act as neurogenic niche cues during cortical development |
Philosophical Transactions of the Royal Society B: Biological Sciences 367 … , 2012 |
2012 |
| Q23 A double blind, cross over, placebo-controlled, phase II trial of Sativex in Huntington's Disease |
Journal of Neurology, Neurosurgery and Psychiatry 83 (Suppl 1), A62 , 2012 |
2012 |
| Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects |
Neuropharmacology 62 (7), 2299-2308 , 2012 |
2012 |
| Cannabinoids: novel medicines for the treatment of Huntington's disease |
Recent Patents on CNS Drug Discovery (Discontinued) 7 (1), 41-48 , 2012 |
2012 |
| Cannabinoids: a new hope for breast cancer therapy? |
Cancer treatment reviews 38 (7), 911-918 , 2012 |
2012 |
| 689 A Role for GPR55 in Multistage Mouse Skin Carcinogenesis |
european journal of cancer, S163 , 2012 |
2012 |
| Neuroprotective effects of Phytocannabinoid-based medicines in experimental models of Huntington's disease |
Congresso Monotematico SIF-“I Cannabinoidi dalla Biologia alla Clinica , 2011 |
2011 |
| Hippocampal proliferative processes are needed for behavioral effects of cannabidiol |
Programa , 2011 |
2011 |
| Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease |
Brain , 2011 |
2011 |
| Neuroprotective effects of phytocannabinoid‐based medicines in experimental models of Huntington's disease |
Journal of neuroscience research 89 (9), 1509-1518 , 2011 |
2011 |
| Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy |
Cell Death & Differentiation 18 (7), 1099-1111 , 2011 |
2011 |
| Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55 |
Molecular Endocrinology 25 (11), 1835-1848 , 2011 |
2011 |
| Symptom‐relieving and neuroprotective effects of the phytocannabinoid Δ 9 ‐THCV in animal models of Parkinson's disease |
British journal of pharmacology 163 (7), 1495-1506 , 2011 |
2011 |
| Fatty acid amide hydrolase as a target for neuroprotection |
MULTIPLE SCLEROSIS JOURNAL 17, S431-S431 , 2011 |
2011 |
| Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action |
Springernature , 2011 |
2011 |
| Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death |
Autophagy 7 (9), 1071-1073 , 2011 |
2011 |
| Virtual laboratory for simulation and learning of cardiovascular system function in BME studies |
|
2011 |
| Reply: Reliability of immunolabelling in the determination of Huntington's disease neuropathy |
Brain 134 (11), e192-e192 , 2011 |
2011 |
| The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK |
Oncogene 30 (2), 245-252 , 2011 |
2011 |
| REGULATION OF NEURAL PROGENITOR CELL BIOLOGY BY THE ENDOCANNABINOID SYSTEM |
JOURNAL OF NEUROCHEMISTRY 118, 26-26 , 2011 |
2011 |
| The role of AMPK in antitumoral action of cannabinoids on HCC |
FEBS JOURNAL 278, 238-238 , 2011 |
2011 |
| A combined preclinical therapy of cannabinoids and temozolomide against glioma |
Molecular cancer therapeutics 10 (1), 90-103 , 2011 |
2011 |
| Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults |
PloS one 6 (8), e23690 , 2011 |
2011 |
| Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease |
Brain 134 (1), 119-136 , 2011 |
2011 |
| Prospects for cannabinoid therapies in basal ganglia disorders |
British journal of pharmacology 163 (7), 1365-1378 , 2011 |
2011 |
| Detecting autophagy in response to ER stress signals in cancer |
Methods in enzymology 489, 297-317 , 2011 |
2011 |
| CANNABINOID SIGNALING IN NEUROGENIC STEM CELL NICHES |
GLIA 59, S17-S18 , 2011 |
2011 |
| The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK |
Oncogene 30 (2), 245-252 , 2011 |
2011 |
| Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action |
Cell Death & Differentiation 18 (6), 959-973 , 2011 |
2011 |
| Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease |
Brain 134 (1), 119-136 , 2011 |
2011 |
| Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism |
Antioxidants & redox signaling 14 (12), 2347-2360 , 2011 |
2011 |
| 356 The putative cannabinoid receptor GPR55 participates in the control of cancer cell proliferation |
European Journal of Cancer Supplements 8 (5), 91 , 2010 |
2010 |
| ROLE OF SPHINGOLIPID TRAFFICKING IN CANNABINOID-INDUCED AUTOPHAGY |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 382, 13-13 , 2010 |
2010 |
| The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors |
Neurobiology of disease 37 (2), 434-440 , 2010 |
2010 |
| Linking ER stress to autophagy: potential implications for cancer therapy |
International journal of cell biology 2010 (1), 930509 , 2010 |
2010 |
| Synthesis and pharmacological evaluation of new (E)-and (Z)-3-aryl-4-styryl-1H-pyrazoles as potential cannabinoid ligands |
Arkivoc 2010, 226-247 , 2010 |
2010 |
| Derivados de cromenopirazoles como ligandos de receptores de cannabinoides |
|
2010 |
| Different Susceptibility to the Parkinson’s Toxin MPTP in Mice Lacking the |
|
2010 |
| Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1 |
PloS one 5 (7), e11838 , 2010 |
2010 |
| The endocannabinoid system as a target for the treatment of neuronal damage |
Expert opinion on therapeutic targets 14 (4), 387-404 , 2010 |
2010 |
| The endocannabinoid system as a target for the treatment of neuronal damage |
Expert opinion on therapeutic targets 14 (4), 387-404 , 2010 |
2010 |
| The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK |
Springernature , 2010 |
2010 |
| [P2.61]: CB 1 cannabinoid receptors regulate pyramidal neuron layer specification |
International Journal of Developmental Neuroscience 28 (8), 708-708 , 2010 |
2010 |
| Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease |
Oxford University Press , 2010 |
2010 |
| Cannabinoid–dopamine interaction in the pathophysiology and treatment of CNS disorders |
CNS neuroscience & therapeutics 16 (3), e72-e91 , 2010 |
2010 |
| A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice |
PloS one 5 (7), e11464 , 2010 |
2010 |
| Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition |
Molecular cancer 9 (1), 1-11 , 2010 |
2010 |
| Use of CB2 receptor agonists for promoting neurogenesis |
US Patent App. 12/306,636 , 2010 |
2010 |
| et-al Factores asociados a la incidencia de tuberculosis en un centro de salud urbano marginal de lima1999-2008 |
Ciencia e investigación 13 (1), 23-29 , 2010 |
2010 |
| Cromenopyrazole derivatives as cannabinoid receptor ligands |
|
2010 |
| Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain |
European Journal of Neuroscience 31 (8), 1414-1422 , 2010 |
2010 |
| Hydrosoluble cannabinoid compounds: synthesis, biological evaluation and metabolism studies |
|
2010 |
| Cannabinoids and Parkinson's disease |
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS … , 2009 |
2009 |
| Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas |
Drug and alcohol dependence 99 (1-3), 354-358 , 2009 |
2009 |
| The endocannabinoid system in neuropathological states |
International Review of Psychiatry 21 (2), 172-180 , 2009 |
2009 |
| Amphiregulin is a factor for resistance of glioma cells to cannabinoid‐induced apoptosis |
Glia 57 (13), 1374-1385 , 2009 |
2009 |
| Amphiregulin Is a Factor for Resistance of Glioma Cells to Cannabinoid-Induced Apoptosis |
Wiley , 2009 |
2009 |
| Endocannabinoides: un nuevo sistema de comunicación en el cerebro |
Monografías de la Real Academia Nacional de Farmacia , 2009 |
2009 |
| Regulation of microglial activation by CB2 cannabinoid receptors is neuroprotective against Huntington's disease excitotoxicity: 43 |
Journal of Neurochemistry 110 , 2009 |
2009 |
| Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma |
Molecular cancer therapeutics 8 (7), 1838-1845 , 2009 |
2009 |
| Actualización sobre el potencial terapéutico de los cannabinoides |
Actualización sobre el potencial terapéutico de los cannabinoides , 2009 |
2009 |
| Cannabinoid CB 1 Receptors are Early DownRegulated Followed by a Further UpRegulation in the Basal Ganglia of Mice with Deletion of Specific Park Genes |
Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra, 269-275 , 2009 |
2009 |
| Microglial CB 2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity |
Brain 132 (11), 3152-3164 , 2009 |
2009 |
| Potencial de los cannabinoides en el tratamiento de la enfermedad de Huntington |
Actualización sobre el potencial terapéutico de los cannabinoides, 105-126 , 2009 |
2009 |
| The endocannabinoid system as a target for the treatment of motor dysfunction |
British journal of pharmacology 156 (7), 1029-1040 , 2009 |
2009 |
| TRB3 links ER stress to autophagy in cannabinoid antitumoral action |
Autophagy 5 (7), 1048-1049 , 2009 |
2009 |
| Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration |
PloS one 4 (6), e5777 , 2009 |
2009 |
| Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity |
Oxford University Press , 2009 |
2009 |
| Regulation of microglial activation by CB2 cannabinoid receptors is neuroprotective against Huntington's disease excitotoxicity |
JOURNAL OF NEUROCHEMISTRY 110, 17-17 , 2009 |
2009 |
| Cannabinoid CB 2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease |
Glia 57 (11), 1154-1167 , 2009 |
2009 |
| Cannabinoids, multiple sclerosis and neuroprotection |
Expert review of clinical pharmacology 2 (6), 645-660 , 2009 |
2009 |
| Mandarin Translations |
|
2009 |
| NOVEL CB1 CANNABINOID LIGANDS: CHROMENOPYRAZOLES |
DRUGS OF THE FUTURE 34, 141-141 , 2009 |
2009 |
| Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells |
The Journal of clinical investigation 119 (5), 1359-1372 , 2009 |
2009 |
| THE ENDOCANNABINOID SYSTEM AND THE REGULATION OF NEUROGENESIS |
JOURNAL OF NEUROCHEMISTRY 110, 157-157 , 2009 |
2009 |
| BIS-PYRAZOLE-3-CARBOXAMIDES AS CANNABINOIDS. IN VITRO AND IN VIVO CHARACTERIZATION |
DRUGS OF THE FUTURE 34, 216-216 , 2009 |
2009 |
| The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders |
European archives of psychiatry and clinical neuroscience 259, 371-382 , 2009 |
2009 |
| The endocannabinoid system in Huntington's disease |
Current pharmaceutical design 14 (23), 2317-2325 , 2008 |
2008 |
| JunD is involved in the antiproliferative effect of Δ9-tetrahydrocannabinol on human breast cancer cells |
Oncogene 27 (37), 5033-5044 , 2008 |
2008 |
| Mechanisms of control of neuron survival by the endocannabinoid system |
Current pharmaceutical design 14 (23), 2279-2288 , 2008 |
2008 |
| The CB2 cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of animal model of multiple sclerosis |
Elsevier , 2008 |
2008 |
| Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth … |
Neuroscience 153 (3), 687-699 , 2008 |
2008 |
| Targeting Cannabinoid Receptors in Brain Tumors |
Cannabinoids and the Brain, 361-374 , 2008 |
2008 |
| The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis |
THE JOURNAL OF BIOLOGICAL CHEMISTRY 283 (9), 5971 , 2008 |
2008 |
| Editorial [Hot topic: Endocannabinoid Signaling and Neuroinflammatory Diseases (Executive Editor: Mauro Maccarrone)] |
Current pharmaceutical design 14 (23), 2252-2253 , 2008 |
2008 |
| Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? |
Neuropharmacology 54 (1), 235-243 , 2008 |
2008 |
| Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? |
PERGAMON-ELSEVIER SCIENCE LTD , 2008 |
2008 |
| The endocannabinoid system in the physiology and pathology of the basal ganglia |
Cannabinoids and the Brain, 423-483 , 2008 |
2008 |
| The CB2 cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis |
Journal of Biological Chemistry 283 (19), 13320-13329 , 2008 |
2008 |
| Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning |
Proceedings of the National Academy of Sciences 105 (25), 8760-8765 , 2008 |
2008 |
| The endocannabinoid system as a target for the treatment of motor dysfunction |
Fundamental and Clinical Pharmacology 22 , 2008 |
2008 |
| Role of CB2 receptors in neuroprotective effects of cannabinoids |
Molecular and cellular endocrinology 286 (1-2), S91-S96 , 2008 |
2008 |
| Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression |
Cancer research 68 (6), 1945-1952 , 2008 |
2008 |
| Antitumoural effect of cannabinoids in an animal model of breast cancer |
EJC Supplements 9 (6), 18 , 2008 |
2008 |
| Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis? |
Cell adhesion & migration 2 (4), 246-248 , 2008 |
2008 |
| Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats |
Neuroscience letters 438 (1), 10-13 , 2008 |
2008 |
| The endocannabinoid system as a target for the treatment of motor dysfunction: S7. 2 |
Fundamental and Clinical Pharmacology 22 , 2008 |
2008 |
| CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats |
Neuropharmacology 54 (6), 976-988 , 2008 |
2008 |
| S. 08.03 Neuroprotective effects of CB2 receptors |
European Neuropsychopharmacology, S171 , 2008 |
2008 |
| The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. VOLUME 282 (2007) PAGES 23892-23898 |
Journal of Biological Chemistry 283 (9), 5971 , 2008 |
2008 |
| Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression |
American Association for Cancer Research , 2008 |
2008 |
| Targeting cannabinoid receptors in brain tumors |
Cannabinoids and the Brain, 361-374 , 2008 |
2008 |
| Cannabidiol reduced the striatal atrophy caused 3‐nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV 1 and adenosine A … |
European Journal of Neuroscience 26 (4), 843-851 , 2007 |
2007 |
| Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties |
Brain research 1134, 162-170 , 2007 |
2007 |
| 410 POSTER Involvement of AP-1 in cannabinoid antiproliferative action |
European Journal of Cancer Supplements 5 (4), 86 , 2007 |
2007 |
| Expresion and function of the endocannabinoid system in neural progenitor cells |
JOURNAL OF NEUROCHEMISTRY 101, 8-8 , 2007 |
2007 |
| The emerging functions of endocannabinoid signaling during CNS development |
Trends in pharmacological sciences 28 (2), 83-92 , 2007 |
2007 |
| Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties |
Brain Research 1134 (1), 162-170 , 2007 |
2007 |
| The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain |
Brain research 1145, 48-55 , 2007 |
2007 |
| THE ENDOCANNABINOID SYSTEM AS THE INTERFACE BETWEEN THE CENTRAL NERVOUS SYSTEM AND THE IMMUNE SYSTEM |
Neuroimmunology Research Perpectives, 207 , 2007 |
2007 |
| Expression and function of the endocannabinoid system in neural progenitor cells |
JOURNAL OF NEUROCHEMISTRY 102, 83-83 , 2007 |
2007 |
| Role of endogenous cannabinoids in the control of basal ganglia activity |
The Basal Ganglia Pathophysiology: Recent Advances, 75-95 , 2007 |
2007 |
| Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol |
Neuroscience letters 421 (3), 270-274 , 2007 |
2007 |
| Cannabinoids and gliomas |
Molecular neurobiology 36, 60-67 , 2007 |
2007 |
| Cannabinoids and neuroprotection in basal ganglia disorders |
Molecular neurobiology 36 (1), 82-91 , 2007 |
2007 |
| Importance of tree revenues and incentives from the programme" coffee-practices" of Starbucks for coffee farmers in Costa Rica and Guatemala. |
|
2007 |
| Ontogeny of the cannabinoid signaling system in the developing brain |
JOURNAL OF NEUROCHEMISTRY 102, 82-83 , 2007 |
2007 |
| The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis |
Journal of Biological Chemistry 282 (33), 23892-23898 , 2007 |
2007 |
| Use of CB2 receptors agonists for the treatment of Huntington's disease |
US Patent App. 11/642,615 , 2007 |
2007 |
| Cannabinoids Induce Glioma Stem-like Cell Differentiation and Inhibit Gliomagenesis |
Elsevier , 2007 |
2007 |
| Cannabinoid CB2 receptor: a new target for controlling neural cell survival? |
Trends in pharmacological sciences 28 (1), 39-45 , 2007 |
2007 |
| Role of the cannabinoid CB2 receptor in the development of experimental autoimmune encephalomyelitis |
JOURNAL OF NEUROCHEMISTRY 101, 58-58 , 2007 |
2007 |
| Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis |
Journal of Biological Chemistry 282 (9), 6854-6862 , 2007 |
2007 |
| The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis |
Elsevier , 2007 |
2007 |
| Cannabinoids and neuroprotection in basal ganglia disorders |
Molecular neurobiology 36, 82-91 , 2007 |
2007 |
| Preface: cannabinoids as new tools for the treatment of neurological disorders |
Molecular neurobiology 36 (1), 1-2 , 2007 |
2007 |
| INCLUDING TOXICOLOGICAL SCIENCES |
Sciences 28 (2), 47-102 , 2007 |
2007 |
| Cannabinoids and Gliomas |
Springer , 2007 |
2007 |
| The endocannabinoid system and neurogenesis in health and disease |
The Neuroscientist 13 (2), 109-114 , 2007 |
2007 |
| Cannabinoids and neuroprotection in motor-related disorders |
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS … , 2007 |
2007 |
| Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions |
Life sciences 80 (10), 979-988 , 2007 |
2007 |
| Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice |
European Journal of Neuroscience 24 (7), 1874-1884 , 2006 |
2006 |
| The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells |
Society for Neuroscience , 2006 |
2006 |
| R-(+)-[2, 3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1, 2, 3-de]-1, 4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune … |
Biochemical pharmacology 72 (12), 1697-1706 , 2006 |
2006 |
| 6.4. Cannabis. 6.4. 1. Bases biológicas |
Tratado SET de Trastornos Adictivos, 222-225 , 2006 |
2006 |
| Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice |
European Journal of Neuroscience. , 2006 |
2006 |
| Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice |
Brain research 1107 (1), 199-205 , 2006 |
2006 |
| Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation |
Cancer research 66 (13), 6615-6621 , 2006 |
2006 |
| Regulation of heme oxygenase-1 gene expression through the phosphatidylinositol 3-kinase/PKC-zeta pathway and Sp1. |
Free Radical Biology and Medicine , 2006 |
2006 |
| Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease |
Brain research 1073, 209-219 , 2006 |
2006 |
| UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the … |
European neuropsychopharmacology 16 (1), 7-18 , 2006 |
2006 |
| from Instituto de Investigaciones Biomédicas and Departamento de Bioquímica, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain. |
|
2006 |
| The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells |
Journal of Neuroscience 26 (5), 1551-1561 , 2006 |
2006 |
| Number 1—January 2006 |
European Neuropsychopharmacology 16, 643-648 , 2006 |
2006 |
| 11 Endocannabinoids and Dopamine-Related Functions in the CNS |
Endocannabinoids, 261 , 2006 |
2006 |
| Ion Channels as a Target for Drug Design |
Current Pharmaceutical Design 12 (18) , 2006 |
2006 |
| Non‐psychoactive CB 2 cannabinoid agonists stimulate neural progenitor proliferation |
Wiley , 2006 |
2006 |
| CYP3A, 178 |
European Neuropsychopharmacology 16, 625-629 , 2006 |
2006 |
| Regulation of heme oxygenase-1 gene expression through the phosphatidylinositol 3-kinase/PKC-zeta pathway and Sp1 |
ELSEVIER SCIENCE INC , 2006 |
2006 |
| Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1‐mediated calcium responses in adult DRG neurons; the role of CB1 receptors |
European Journal of Neuroscience 24 (12), 3489-3495 , 2006 |
2006 |
| Non‐psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation |
The FASEB Journal 20 (13), 2405-2407 , 2006 |
2006 |
| An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments |
Current medicinal chemistry 13 (30), 3705-3718 , 2006 |
2006 |
| A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme |
British journal of cancer 95 (2), 197-203 , 2006 |
2006 |
| Chronic Δ 9 -tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex |
Naunyn-Schmiedeberg's archives of pharmacology 372 (4), 313 , 2006 |
2006 |
| Acyl‐based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations |
Journal of neurochemistry 99 (2), 677-688 , 2006 |
2006 |
| Glycogen synthase kinase-3 beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2 |
Journal of Biological Chemistry , 2006 |
2006 |
| Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development |
Current pharmaceutical design 12 (18), 2319-2325 , 2006 |
2006 |
| Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels |
Biochemical pharmacology 70 (3), 446-452 , 2005 |
2005 |
| Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease |
Brain research 1050 (1-2), 210-216 , 2005 |
2005 |
| Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease |
Neurobiology of disease 19 (1-2), 96-107 , 2005 |
2005 |
| The endocannabinoid system drives neural progenitor proliferation |
The FASEB journal 19 (12), 1704-1706 , 2005 |
2005 |
| Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice |
Brain research 1046 (1-2), 195-206 , 2005 |
2005 |
| Therapeutic potential of the endocannabinoid system in the brain |
Mini reviews in medicinal chemistry 5 (7), 609-617 , 2005 |
2005 |
| Cannabinoids and ceramide: two lipids acting hand-by-hand |
Life sciences 77 (14), 1723-1731 , 2005 |
2005 |
| Understanding the coffee farmer and his environment. |
|
2005 |
| Cannabinoids: Interactions with other drugs |
Elsevier , 2005 |
2005 |
| Cannabinoid control of motor function at the basal ganglia |
Cannabinoids, 479-507 , 2005 |
2005 |
| Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis |
Neurobiology of disease 20 (2), 207-217 , 2005 |
2005 |
| Cannabinoid tolerance and dependence: a review of studies in laboratory animals |
Pharmacology Biochemistry and Behavior 81 (2), 300-318 , 2005 |
2005 |
| Cannabinoids in neurodegeneration and neuroprotection |
Cannabinoids as Therapeutics, 79-109 , 2005 |
2005 |
| The endocannabinoid system drives neural progenitor proliferation |
Wiley , 2005 |
2005 |
| Editorial| Pharmacology Biochemistry and Behavior-Volume 81, Issue 2 |
Pharmacology Biochemistry and Behavior 81 (2), 221-223 , 2005 |
2005 |
| Effects of neonatal exposure to methamphetamine: catecholamine levels in brain areas of the developing rat |
Annals of the New York Academy of Sciences 1025 (1), 602-611 , 2004 |
2004 |
| Síndrome del túnel del carpo: Correlación clínica y neurofisiológica |
Anales de la Facultad de Medicina 65 (4), 247-254 , 2004 |
2004 |
| In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake |
European journal of pharmacology 484 (2-3), 249-257 , 2004 |
2004 |
| Involvement of the endocannabinoid system in motor disorders |
Current Medicinal Chemistry-Central Nervous System Agents 4 (3), 175-182 , 2004 |
2004 |
| Prenatal exposure to methamphetamine in the rat: animal model and postnatal effects upon dopaminergic areas |
Fundamental and Clinical Pharmacology Supplement 18 , 2004 |
2004 |
| Therapy with cannabinoid compounds for the treatment of brain tumors |
US Patent App. 10/647,739 , 2004 |
2004 |
| Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo |
Neuroreport 15 (15), 2375-2379 , 2004 |
2004 |
| Hypothesis: cannabinoid therapy for the treatment of gliomas? |
Neuropharmacology 47 (3), 315-323 , 2004 |
2004 |
| Endocannabinoids and alcohol addiction |
Recent advances in pharmacology and physiology of cannabinoids 2004, 237-246 , 2004 |
2004 |
| Cannabinoids and gene expression during brain development |
Neurotoxicity research 6 (5), 389-401 , 2004 |
2004 |
| Behavioral and molecular changes elicited by acute administration of SR141716 to Δ9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence |
Drug and alcohol dependence 74 (2), 159-170 , 2004 |
2004 |
| Changes in endocannabinoid contents in reward‐related brain regions of alcohol‐exposed rats, and their possible relevance to alcohol relapse |
British journal of pharmacology 143 (4), 455-464 , 2004 |
2004 |
| Carpal tunnel syndrome: Clinical and neurophysiological correlation |
Anales de la Facultad de Medicina 65 (4), 247-254 , 2004 |
2004 |
| Transthyretin is involved in depression‐like behaviour and exploratory activity |
Journal of neurochemistry 88 (5), 1052-1058 , 2004 |
2004 |
| Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal Δ 9 -tetrahydrocannabinol exposure |
The Cerebellum 3 (2), 66-74 , 2004 |
2004 |
| Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence |
Brain research 1007 (1-2), 152-159 , 2004 |
2004 |
| Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease |
Journal of neurochemistry 84 (5), 1097-1109 , 2003 |
2003 |
| Prenatal cannabinoid exposure and gene expression for neural adhesion molecule L1 in the fetal rat brain |
Developmental brain research 147 (1-2), 201-207 , 2003 |
2003 |
| Actualización de los conocimientos acerca del uso terapéutico de los cannabinoides |
Actualización de los conocimientos acerca del uso terapéutico de los … , 2003 |
2003 |
| Regulación de la secreción del factor de crecimiento nervioso en células gliales: mecanismos de transducción a través de mensajeros lipídicos |
Universidad Complutense de Madrid, Servicio de Publicaciones , 2003 |
2003 |
| Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors |
European journal of medicinal chemistry 38 (4), 403-412 , 2003 |
2003 |
| The endocannabinoid system and Huntington's disease |
Current Drug Targets-CNS & Neurological Disorders 2 (5), 335-347 , 2003 |
2003 |
| Anti-tumoral action of cannabinoids in malignant gliomas |
GLIA, 18-18 , 2003 |
2003 |
| Region‐dependent changes in endocannabinoid transmission in the brain of morphine‐dependent rats |
Addiction biology 8 (2), 159-166 , 2003 |
2003 |
| Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate |
Neuroreport 14 (6), 813-816 , 2003 |
2003 |
| Cannabinoid inhibition of neuronal differentiation |
JOURNAL OF NEUROCHEMISTRY 87, 17-17 , 2003 |
2003 |
| Effects of perinatal exposure to Δ9-tetrahydrocannabinol on operant morphine-reinforced behavior |
Pharmacology Biochemistry and Behavior 75 (3), 577-584 , 2003 |
2003 |
| Cannabinoids protect astrocytes from apoptosis |
GLIA, 18-18 , 2003 |
2003 |
| Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study |
Sleep 26 (8), 943-947 , 2003 |
2003 |
| Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase |
Journal of medicinal chemistry 46 (8), 1512-1522 , 2003 |
2003 |
| Ceramide Signaling in Cannabinoid Action |
Ceramide Signaling, 125-132 , 2003 |
2003 |
| Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats |
Addiction Biology 8 (2), 159-166 , 2003 |
2003 |
| Propuesta de Manejo de la Nutrición Parenteral en pacientes pediátricos hospitalizados en el Hospital Regional de Occidente, San Juan de Dios |
Tesis Licenciatura en Nutrición). Universidad de San Carlos de Guatemala … , 2003 |
2003 |
| SISTEMA ENDOCANNABINOIDE Y SU POSIBLE PARTICIPACION EN EL ALCOHOLISMO Y OTRAS DROGODEPENDENCIAS |
ADICCIONES-PALMA DE MALLORCA- 15, 43-43 , 2003 |
2003 |
| Pharmacology and Therapeutics: Preface |
Pharmacology and Therapeutics: Preface 95 (2), 101-102 , 2002 |
2002 |
| Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis |
The Journal of cell biology 158 (6), 1039-1049 , 2002 |
2002 |
| Prenatal exposure to methamphetamine in the rat: ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons |
Annals of the New York Academy of Sciences 965 (1), 68-77 , 2002 |
2002 |
| Direct calcium binding results in activation of brain serine racemase |
Journal of Biological Chemistry 277 (31), 27782-27792 , 2002 |
2002 |
| Blockade of cannabinoid CB1 receptor function protects against in vivo disseminating brain damage following NMDA‐induced excitotoxicity |
Journal of neurochemistry 82 (1), 154-158 , 2002 |
2002 |
| Cannabinoids and cell fate |
Pharmacology & therapeutics 95 (2), 175-184 , 2002 |
2002 |
| Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington’s disease |
Brain research 929 (2), 236-242 , 2002 |
2002 |
| UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide |
European journal of pharmacology 449 (1-2), 99-103 , 2002 |
2002 |
| The endogenous cannabinoid system and the basal ganglia: biochemical, pharmacological, and therapeutic aspects |
Pharmacology & therapeutics 95 (2), 137-152 , 2002 |
2002 |
| STR data for nine Y-chromosomal loci in Guinea Equatorial (central Africa) |
Forensic Sci Int 127 (1-2), 142-144 , 2002 |
2002 |
| De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis |
Biochemical Journal 363 (1), 183-188 , 2002 |
2002 |
| Exposure to cannabinoids in the development of endogenous cannabinoid system |
Neurotoxicity research 4 (4), 363-372 , 2002 |
2002 |
| Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels |
Drug and alcohol dependence 66 (1), 77-84 , 2002 |
2002 |
| Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine |
Brain research 954 (1), 73-81 , 2002 |
2002 |
| The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway |
Journal of Biological Chemistry 277 (48), 46645-46650 , 2002 |
2002 |
| Hansen, HH, 119 Harris, D., 191 Henry, PJ, 239 Honoré, JC, 221 |
Pharmacology & Therapeutics 95, 305 , 2002 |
2002 |
| Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease |
Synapse 44 (1), 23-35 , 2002 |
2002 |
| Erratum:" The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats"(Life Sciences (2002) 70: 12 (1407-1414) PII … |
Erratum:" The hypothalamic levels of the endocannabinoid, anandamide, peak … , 2002 |
2002 |
| Workshop on new perspectives on therapeutical use of endocannabinoids-Preface |
PHARMACOLOGY & THERAPEUTICS 95 (2), 101-102 , 2002 |
2002 |
| Loss of cannabinoid CB 1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease |
Neurotoxicity research 4 (7-8), 601-608 , 2002 |
2002 |
| Mechanism of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor |
Molecular pharmacology 62 (6), 1385-1392 , 2002 |
2002 |
| The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats |
Life sciences 70 (12), 1407-1414 , 2002 |
2002 |
| Astroglial response to cannabinoids in the rat cerebellum |
GLIA, S53-S53 , 2002 |
2002 |
| Endogenous cannabinoids and brain development |
European Neuropsychopharmacology, 128 , 2002 |
2002 |
| Endocannabinoids and basal ganglia functionality |
Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 66 (2-3), 257-267 , 2002 |
2002 |
| The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan |
Molecular pharmacology 59 (5), 955-959 , 2001 |
2001 |
| Bases moleculares y farmacológicas de la tolerancia/dependencia a cannabinoides |
Conductas adictivas , 2001 |
2001 |
| Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues |
European journal of pharmacology 420 (2-3), 123-131 , 2001 |
2001 |
| Inhibition of Glioma Growth in Vivo by Selective Activation of the CB 2 Cannabinoid Receptor |
Cancer research 61 (15), 5784-5789 , 2001 |
2001 |
| Control of the cell survival/death decision by cannabinoids |
Journal of molecular medicine 78, 613-625 , 2001 |
2001 |
| Control of the cell survival/death decision by cannabinoids |
Journal of molecular medicine 78 (11), 613-625 , 2001 |
2001 |
| The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan |
Molecular Pharmacology 59 (5), 955-959 , 2001 |
2001 |
| Signaling at zero g: a comment |
Trends in Biochemical Sciences 26 (9), 533 , 2001 |
2001 |
| Changes in cannabinoid CB 1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis |
Synapse 41 (3), 195-202 , 2001 |
2001 |
| Ceramide: a new second messenger of cannabinoid action |
Trends in pharmacological sciences 22 (1), 19-22 , 2001 |
2001 |
| Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors |
Journal of medicinal chemistry 44 (26), 4505-4508 , 2001 |
2001 |
| Nuevas tendencias en la utilidad terapeútica de los cannabinoides |
Anales de la Real Sociedad Española de Química, 14-21 , 2001 |
2001 |
| Signaling at zero g: a comment |
Trends in biochemical sciences 26 (9), 533 , 2001 |
2001 |
| Effects of cannabinoids on adrenaline release from adrenal medullary cells |
British journal of pharmacology 134 (6), 1319-1327 , 2001 |
2001 |
| Increased cannabinoid CB 1 receptor binding and activation of GTP‐binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP … |
European Journal of Neuroscience 14 (11), 1827-1832 , 2001 |
2001 |
| Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease |
Neuroreport 12 (10), 2125-2129 , 2001 |
2001 |
| Neonatal methamphetamine in the rat: evidence for gender‐specific differences upon tyrosine hydroxylase enzyme in the dopaminergic nigrostriatal system |
Annals of the New York Academy of Sciences 914 (1), 431-438 , 2000 |
2000 |
| Cannabinoides: propiedades químicas y aspectos metabólicos |
Monografía cannabis, 41 , 2000 |
2000 |
| Prenatal Δ9-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences |
Developmental Brain Research 120 (1), 77-81 , 2000 |
2000 |
| The endogenous cannabinoid system and brain development |
Trends in neurosciences 23 (1), 14-20 , 2000 |
2000 |
| Unilateral 6-Hydroxydopamine Lesions of Nigrostriatal Dopaminergic Neurons Increased Cannabinoid CB 1 Receptor mRNA Levels in the Rat Striatum: Possible … |
Neurotoxic Factors in Parkinson’s Disease and Related Disorders, 301-305 , 2000 |
2000 |
| Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation |
Nature medicine 6 (3), 313-319 , 2000 |
2000 |
| Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen |
Life sciences 66 (6), 485-494 , 2000 |
2000 |
| Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ 9 ‐Tetrahydrocannabinol … |
Journal of neurochemistry 74 (4), 1627-1635 , 2000 |
2000 |
| Sex steroid influence on cannabinoid CB1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland |
Biochemical and biophysical research communications 270 (1), 260-266 , 2000 |
2000 |
| Part VIII Prenatal Exposure and Postnatal Outcome-Neonatal Methamphetamine in the Rat: Evidence for Gender-specific Differences upon Tyrosine Hydroxylase Enzyme in the … |
Annals of the New York Academy of Sciences-Paper Edition 914, 431-438 , 2000 |
2000 |
| Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death |
Proceedings of the National Academy of Sciences 97 (14), 7859-7864 , 2000 |
2000 |
| Decreased cannabinoid CB1 receptor mRNA levels and immunoreactivity in pituitary tumors induced by prolonged exposure to estrogens |
Pituitary 3 (4), 221-227 , 2000 |
2000 |
| Endogenous cannabinoid system: ligands and receptors matched to transduction signals mechanisms |
ADICCIONES-PALMA DE MALLORCA- 12, 59-82 , 2000 |
2000 |
| Cannabinoids: chemical and metabolic characteristics |
ADICCIONES-PALMA DE MALLORCA- 12, 41-58 , 2000 |
2000 |
| Sistema cannabinoide endógeno: ligandos y receptores acoplados a mecanismos de transducción de señales |
Adicciones 12 (5), 59-81 , 2000 |
2000 |
| The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase |
Molecular pharmacology 58 (4), 814-820 , 2000 |
2000 |
| Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme |
Brain research 857 (1-2), 56-65 , 2000 |
2000 |
| Uso de los cannabinoides a través de la historia |
Adicciones 12 (5), 19-30 , 2000 |
2000 |
| De novo ‐synthesized ceramide signals apoptosis in astrocytes via extracellular signal‐regulated kinase |
The FASEB Journal 14 (14), 2315-2322 , 2000 |
2000 |
| Cannabinoids use through history |
ADICCIONES-PALMA DE MALLORCA- 12, 19-30 , 2000 |
2000 |
| Perinatal Δ9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABAB, but not GABAA, receptor agonists in adult rats |
Neurotoxicology and teratology 21 (3), 277-283 , 1999 |
1999 |
| Time-dependent differences of repeated administration with Δ9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by μ … |
Molecular brain research 67 (1), 148-157 , 1999 |
1999 |
| The Stimulation of Ketogenesis by Cannabinoids in Cultured Astrocytes Defines Carnitine Palmitoyltransferase I as a New Ceramide‐Activated Enzyme |
Journal of neurochemistry 72 (4), 1759-1768 , 1999 |
1999 |
| Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide |
Life sciences 65 (3), 327-336 , 1999 |
1999 |
| Mechanism of C6. 9 glioma cell death by Delta 9-tetrahydrocannabinol |
JOURNAL OF NEUROCHEMISTRY 73, S13-S13 , 1999 |
1999 |
| Role of endocannabinoids in brain development |
Life Sciences 65 (6-7), 725-736 , 1999 |
1999 |
| Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland |
Neuroendocrinology 70 (2), 137-145 , 1999 |
1999 |
| Cannabinoid receptor and WIN-55,212-2-stimulated [35S] GTPγS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to … |
Neurochemistry international 34 (6), 473-482 , 1999 |
1999 |
| Papel del sistema cannabinoide endógeno durante el desarrollo cerebral |
Papel del sistema cannabinoide endógeno durante el desarrollo cerebral , 1999 |
1999 |
| Effects of cannabinoids on energy metabolism |
Life sciences 65 (6), 657-664 , 1999 |
1999 |
| The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide‐activated enzyme |
Journal of neurochemistry 72 (4), 1759-1768 , 1999 |
1999 |
| Pharmacological and biochemical interactions between opioids and cannabinoids |
Trends in Pharmacological Sciences 20 (7), 287-294 , 1999 |
1999 |
| Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland. |
Journal of neuroendocrinology 11 (11), 873-878 , 1999 |
1999 |
| Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells |
FEBS letters 463 (3), 235-240 , 1999 |
1999 |
| MECHANISM OF C6. 9 GLIOMA CELL DEATH BY Δ9-TETRAHYDROCANNABINOL |
Journal of Neurochemistry 73 , 1999 |
1999 |
| Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor‐induced secretion of nerve growth factor in primary astrocyte cultures |
Journal of neurochemistry 71 (2), 498-505 , 1998 |
1998 |
| Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development |
Development 125 (16), 3179-3188 , 1998 |
1998 |
| Role of carnitine palmitoyltransferase I in the control of ketogenesis in primary cultures of rat astrocytes |
Journal of neurochemistry 71 (4), 1597-1606 , 1998 |
1998 |
| Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation |
Life sciences 63 (5), 351-356 , 1998 |
1998 |
| En busca de un sistema cannabinoide endógeno: las anandamidas |
Derivados del cannabis,¿ drogas o medicamentos?: avances en farmacología de … , 1998 |
1998 |
| Δ 9 ‐Tetrahydrocannabinol induces apoptosis in C6 glioma cells |
FEBS letters 436 (1), 6-10 , 1998 |
1998 |
| Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary … |
Molecular pharmacology 54 (5), 834-843 , 1998 |
1998 |
| Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats |
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1407 (3), 205-214 , 1998 |
1998 |
| Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary … |
Molecular Pharmacology 54 (5), 834-843 , 1998 |
1998 |
| Espey, MG, 2079 Estephan, R., 1854 Estus, S., 506 Evans, J., 2239 Evans, LM, 2505 |
J. Neurochem 71 (6) , 1998 |
1998 |
| Perinatal Δ9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats |
Life sciences 63 (10), 843-850 , 1998 |
1998 |
| Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cells |
FEBS letters 436 (1), 6-10 , 1998 |
1998 |
| cAMP signalling mechanisms with aging in the Ceratitis capitata brain |
Mechanisms of ageing and development 97 (1), 45-53 , 1997 |
1997 |
| Atypical location of cannabinoid receptors in white matter areas during rat brain development |
Synapse 26 (3), 317-323 , 1997 |
1997 |
| Adaptations of the β-adrenoceptor-adenylyl cyclase system in rat skeletal muscle to endurance physical training |
Pflügers Archiv 434, 809-814 , 1997 |
1997 |
| Metabolic stimulation of mouse spleen lymphocytes by low doses of 9-tetrahydrocannabinol |
Life sciences 60 (19), 1709-1717 , 1997 |
1997 |
| Ceramide-induced translocation of protein kinase C ζ in primary cultures of astrocytes |
FEBS letters 415 (3), 271-274 , 1997 |
1997 |
| Δ 9 -Tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells |
Brain research 767 (1), 64-71 , 1997 |
1997 |
| Regulation of nerve growth factor secretion and mRNA expression by bacterial lipopolysaccharide in primary cultures of rat astrocytes |
Journal of neuroscience research 49 (5), 569-575 , 1997 |
1997 |
| Effects of chronic exposure to Δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions |
Molecular brain research 46 (1-2), 100-108 , 1997 |
1997 |
| Perinatal Δ9-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats |
Neurotoxicology and teratology 19 (6), 477-487 , 1997 |
1997 |
| Induction of nerve growth factor synthesis by sphingomyelinase and ceramide in primary astrocyte cultures |
Molecular brain research 52 (1), 90-97 , 1997 |
1997 |
| The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake |
Life sciences 62 (4), 351-363 , 1997 |
1997 |
| Involvement of GABA (B) receptors in the motor inhibition produced by agonists of brain cannabinoid receptors. |
Behavioural pharmacology 7 (3), 299-302 , 1996 |
1996 |
| Are cytoskeletal components involved in the control of hepatic carnitine palmitoyltransferase I activity? |
Biochemical and biophysical research communications 224 (3), 754-759 , 1996 |
1996 |
| Levels and activity of brain protein kinase C α and ζ during the aging of the medfly |
Mechanisms of ageing and development 92 (1), 21-29 , 1996 |
1996 |
| Addition of phosphatidylcholine-phospholipase C induces cellular redistribution and phosphorylation of protein kinase C ξ in C 6 glial cells |
Neuroscience letters 219 (1), 68-70 , 1996 |
1996 |
| Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1, receptor ligand |
Life sciences 58 (15), 1249-1257 , 1996 |
1996 |
| Effects of perinatal exposure to Δ 9 -tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain |
Journal of Molecular Neuroscience 7 (4), 291-308 , 1996 |
1996 |
| The prenatal exposure to Δ9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development |
Life sciences 56 (23-24), 2177-2184 , 1995 |
1995 |
| Effects of anandamide on hepatic fatty acid metabolism |
Biochemical pharmacology 50 (6), 885-888 , 1995 |
1995 |
| Phosphatidylcholine‐phospholipase C mediates the induction of nerve growth factor in cultured glial cells |
FEBS letters 364 (3), 301-304 , 1995 |
1995 |
| Community nursing. Repercussions on health centers |
Revista de Enfermeria (Barcelona, Spain) 18 (201), 51-57 , 1995 |
1995 |
| Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function |
Brain research 694 (1-2), 223-232 , 1995 |
1995 |
| Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment |
Pharmacology Biochemistry and Behavior 47 (1), 33-40 , 1994 |
1994 |
| The putative cannabinoid receptor ligand anandamide, stimulates hypothalamic tyrosine hydroxylase activity and inhibits prolactin release |
Neuro endocrinology letters 16 (3), 159-164 , 1994 |
1994 |
| Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids |
Developmental brain research 81 (1), 147-150 , 1994 |
1994 |
| Maternal cannabinoid exposure and brain development: changes in the ontogeny of dopaminergic neurons |
Neurobiology and neurophysiology of cannabinoids, biochemistry and … , 1992 |
1992 |
| Comparisons between brain dopaminergic neurons of juvenile and aged rats: sex-related differences |
Mechanisms of ageing and development 63 (1), 45-55 , 1992 |
1992 |
| Possible Role Of Prolactin As Neuromodulator Of Extrahypothalamic Dopaminergic Activity |
Behavioural Pharmacology 3, 94-96 , 1992 |
1992 |
| Time-dependent effects of ovarian steroids on tyrosine hydroxylase activity in the limbic forebrain of female rats |
Journal of Neural Transmission/General Section JNT 83 (1-2), 77-84 , 1991 |
1991 |
| Necesidad de capacitacion de la Direccion de Conservacion y evaluacion de tierras de MARNR [Ministerio de Ambiente y de los Recursos Naturales Renovables]. |
|
1991 |
| [Training need of the Directorate of soil conservation and soil evaluation of MARNR [Ministry of the Environment and Renewable Natural Resources]] |
|
1991 |
| Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats |
Journal of Neural Transmission/General Section JNT 85 (3), 223-229 , 1991 |
1991 |
| TIME-COURSE OF THE EFFECTS OF OVARIAN STEROIDS ON PITUITARY PROLACTIN RELEASE: LACK OF CORRELATION WITH THE CHANGES IN THE ACTIVITY OF TUBEROINFUNDIB ULAR DOPAMINERGIC NEURONS |
Neuro endocrinology letters 13 (2), 67-73 , 1991 |
1991 |
| Is prolactin playing a role in the regulation of catecholamine synthesis and release from male rat adrenal medulla? |
Journal of endocrinological investigation 14 (3), 201-208 , 1991 |
1991 |
| Bases neuroquímicas de la conducta |
Psicología médica, psicopatología y psiquiatría, 79-117 , 1990 |
1990 |
| Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain |
Pharmacology Biochemistry and Behavior 36 (3), 603-606 , 1990 |
1990 |
| Prolactin inhibits the activity of tyrosine hydroxylase in cultured bovine adrenal chromaffin cells in a dose-dependent manner |
Brain research 528 (1), 175-178 , 1990 |
1990 |
| Role of ovarian steroids on the catecholamine synthesis and release in female rat adrenal: in vivo and in vitro studies |
Life sciences 44 (25), 1979-1986 , 1989 |
1989 |
| Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors |
Brain research 476 (2), 388-395 , 1989 |
1989 |
| 2-Hydroxyestradiol is not mediating the effects of estradiol on tuberoinfundibular dopaminergic neurons controlling prolactin secretion in female rats |
Journal of steroid biochemistry 32 (1), 71-75 , 1989 |
1989 |
| Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia |
Molecular and cellular endocrinology 58 (2-3), 167-173 , 1988 |
1988 |
| Role of estrogens on striatal dopaminergic activity |
Journal of steroid biochemistry 27 (4-6), 683-689 , 1987 |
1987 |
| Effect of elevated prolactin levels on the synthesis and release of catecholamines from the adrenal medulla in female rats |
Neuroendocrinology 45 (3), 208-211 , 1987 |
1987 |
| Regulación por dopamina y norepinefrina de la secreción de prolactina en la hiperprolactinemia inducida experimentalmente |
Universidad Complutense de Madrid , 1986 |
1986 |
